The liver is the primary site for the production of both circulating insulin-like growth factor 1 (IGF-1) (Kita et al., 1996) and
plasma triiodothyronine (T3) through thyroxin (T4) deiodination, both processes being under the control of GH via hepatic GH receptor (Burnside and Cogburn, 1992).